Pre-operative epirubicin, capecitabine (Xeloda) and cisplatin in patients with newly diagnosed localised oesophageal adenocarcinoma.
Phase of Trial: Phase II
Latest Information Update: 22 Dec 2009
At a glance
- Drugs Capecitabine (Primary) ; Cisplatin; Epirubicin
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 22 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Nov 2005 New trial record.